Abstract
Abstract
Novel ST398 methicillin susceptible Staphylococcus aureus (MSSA) in the United States was first observed in New York City (2004–2007); its diffusion across the country resulted in changing treatment options. Utilizing outpatient antimicrobial susceptibility data from the Veterans Health Administration from 2010 to 2019, the spatiotemporal prevalence of potential ST398 MSSA is documented.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference10 articles.
1. Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014;Carrel;Antimicrob Resist Infect Contr,2017
2. Reply to Gandra et al
3. Is methicillin-susceptible Staphylococcus aureus (MSSA) sequence type 398 confined to northern Manhattan? Rising prevalence of erythromycin-and clindamycin-resistant MSSA clinical isolates in the United States;Gandra;Clin Infect Dis,2013
4. Methicillin-SusceptibleStaphylococcus aureusST398, New York and New Jersey, USA
5. Evolutionary Dynamics of Pandemic Methicillin-Sensitive
Staphylococcus aureus
ST398 and Its International Spread via Routes of Human Migration